Efficacy and Safety of Various Antibiotics in Bacteremia Caused by AmpC-Producing Enterobacteriaceae, Comparing Carbapenems: A Systematic Review and Network Meta-analysis
Biological and Pharmaceutical Bulletin · 2026
DOI: 10.1248/bpb.b25-00565 ↗Kurz gefasst
Netzwerk-Metaanalyse in der Zeitschrift Biological and Pharmaceutical Bulletin, 2026. Verfasst von Satoru Mitsuboshi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Kaetsu Hospital. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Carbapenems, Bacteremia, Enterobacteriaceae Infections.
Abstract (Originalsprache)
This meta-analysis aimed to evaluate the efficacy and safety of various antibiotics used as definitive therapy for bacteremia caused by AmpC-producing bacteria. MEDLINE via PubMed, the Cochrane Central Register of Controlled Trials, and the ClinicalTrials.gov website were comprehensively searched to identify all relevant studies. Carbapenem served as a reference, and the intervention effects of the other antibiotics were compared. Primary outcomes were all-cause mortality, recurrent infections, and adverse events. A frequentist network meta-analysis was performed using a random-effects model to account for any significant heterogeneity between studies. The odds ratios (ORs) and 95% confidence intervals (CIs) for each outcome in comparison with the carbapenem antibiotic were calculated based on the size of the population. Twelve studies were included in this meta-analysis. There were no significant differences in all-cause mortality or recurrent infections between carbapenems and other individual antibiotics. While cefepime significantly reduced the risk of adverse events compared to carbapenem (OR 0.28, 95% CI 0.14-0.57), and piperacillin-tazobactam showed a tendency to increase the risk of adverse events compared to carbapenem (OR 13.41, 95% CI 0.64-280.80). In conclusion, this meta-analysis found that cefepime was associated with comparable efficacy and fewer adverse events than carbapenems in the treatment of bacteremia caused by AmpC-producing bacteria. Additionally, potential concerns identified regarding the therapeutic efficacy of piperacillin-tazobactam, cephalosporins (excluding cefepime), fluoroquinolones, and aminoglycosides.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Kaetsu Hospital.
- Laboratory of Clinical Pharmacoepidemiology, Kyoto Pharmaceutical University.
Zitieren
APA
Mitsuboshi, S., Inose, R., Yanagisawa, R., Uemoto, K., Mizuno, K., & Muraki, Y. (2026). Efficacy and Safety of Various Antibiotics in Bacteremia Caused by AmpC-Producing Enterobacteriaceae, Comparing Carbapenems: A Systematic Review and Network Meta-analysis. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b25-00565
Vancouver
Mitsuboshi S, Inose R, Yanagisawa R, Uemoto K, Mizuno K, Muraki Y. Efficacy and Safety of Various Antibiotics in Bacteremia Caused by AmpC-Producing Enterobacteriaceae, Comparing Carbapenems: A Systematic Review and Network Meta-analysis. Biological and Pharmaceutical Bulletin. 2026. doi:10.1248/bpb.b25-00565
BibTeX
@article{Mitsuboshi2026,
author = {Mitsuboshi, Satoru and Inose, Ryo and Yanagisawa, Rina and Uemoto, Kana and Mizuno, Kanako and Muraki, Yuichi},
title = {Efficacy and Safety of Various Antibiotics in Bacteremia Caused by AmpC-Producing Enterobacteriaceae, Comparing Carbapenems: A Systematic Review and Network Meta-analysis},
journal = {Biological and Pharmaceutical Bulletin},
year = {2026},
doi = {10.1248/bpb.b25-00565}
}
EUVIMED